Alnylam Pharmaceuticals (United States)

594 papers and 43.3k indexed citations i.

About

In recent decades, authors affiliated with Alnylam Pharmaceuticals (United States) have published 594 papers, which have received a total of 43.3k indexed citations. Scholars at this organization have produced 406 papers in Molecular Biology, 56 papers in Cancer Research and 51 papers in Epidemiology on the topics of RNA Interference and Gene Delivery (165 papers), Advanced biosensing and bioanalysis techniques (119 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (96 papers). Their work is cited by papers focused on Molecular Biology (30.7k citations), Cancer Research (9.0k citations) and Immunology (5.9k citations). Authors at Alnylam Pharmaceuticals (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Nature, Cell and New England Journal of Medicine. Some of Alnylam Pharmaceuticals (United States)'s most productive authors include Muthiah Manoharan, Kallanthottathil G. Rajeev, Victor Koteliansky, Markus Stoffel, Ravi Braich, Akin Akinc, Dinah W.Y. Sah, Thomas Tuschl, Kevin Fitzgerald and Jan Krützfeldt.

In The Last Decade

Fields of papers published by authors at Alnylam Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Alnylam Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Alnylam Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Alnylam Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Alnylam Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Alnylam Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alnylam Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Center for Neuro-Oncology Breakdown of academic impact, for scholars at American Urological Association Breakdown of academic impact, for scholars at Réseau sur le Stockage Electrochimique de l'énergie Breakdown of academic impact, for scholars at MRC Cognition and Brain Sciences Unit Breakdown of academic impact, for scholars at Protein Express (United States) Breakdown of academic impact, for scholars at Greenville College Breakdown of academic impact, for scholars at Cooper Institute Breakdown of academic impact, for scholars at Thinfilm (Sweden)